Jodi a m ap ekri sou yon bagay ki toupre ak renmen kè m. Sa gen twazan, ti frè m nan ak madanm li te fè premye pitit yo. Yo te amoure lekòl klas yo te rankontre youn ak lòt nan 7yèm ane. Apre anpil ane ansanm, yo deside mare ne a. Lè yo finalman te vin ansent fanmi mwen ak mwen te tèlman eksite, nou te plen antisipasyon. Lè Andre te vin sou monn nan, mwen pa ka dekri kijan mwen te kontan pou frè m 'ak madanm li, frè m' ak mwen se 12 ane apa, kidonk mwen te gade l 'grandi. Li te vin yon bon gason konsa, franchman yon pi bon gason pase m ' e onètman mwen te vle l '. Mwen te grandi nan kouri nan lari epi mwen pa t 'vle sa pou li. Se konsa, lè li te gen pitit gason l 'mwen pa t' kapab plis fyè ak kontan. Annapre, apre yon koup ane, ti gason nou an te dyagnostike ak yon ti ka Otis. Manman m, se yon vye fanm ki soti nan zile yo, li pa t sèten sa li te ye. Li te remake yon bagay pa t bon depi byen bon e lè li te konfime li te menm jan ak mwen. Laperèz ak enkyetid mete nan men evantyèlman nou te abitye ak l 'ak eksantrik espesyal komik li yo. Dènyèman, mwen t ap gade yon espesyal sou CNN ak Dr Sanjay Gupta yon doktè ki renome nan lemonn atravè tablo a. Li te vin enterese nan efè yo nan marigwana medikal ak efè pozitif li yo sou timoun ki gen kriz, ki mennen nan espesyal li sou Charlotte Figi yon jèn dam batay 30 kriz yon jou ak yon melanj espesyal lwil Cannabis kounye a ke yo rekonèt kòm entènèt Charlotte a. Lwil Cannabis sa a te fè kriz li yo yon sèl pa semèn sa ki te pèmèt yon pi bon kalite lavi pou li. Malerezman, Covid te pran lavi l nan 2020. Kounye a, nouvo espesyal sa a sou Cannabis ak efè pozitif li sou Otis vrèman frape tou pre lakay ou. Li te pataje istwa yon lòt jèn dam ki te soufri ak Otis grav epi kijan li t ap fè tèt li mal epi li te fè bagay sovaj ki te rann li difisil anpil pou paran li pran swen li. Mwen te chita epi mwen te gade espesyal sa a an antye pou m te gen plis konesans ke mwen te kapab sou sijè a. Efè mirak lwil Cannabis la te genyen sou li ak sou lòt fanmi timoun yo te sezi anpil! Mwen te aprann anpil bagay e sa te ban mwen anpil espwa. Mwen pa menm ka kòmanse pale sou jan mwen santi mwen sou pouvwa sa yo, toujou enpoze yon pwoblèm federal ak marigwana nan peyi Etazini an mwen pral sove sa pou yon lòt jou! Jodi a mwen konte benediksyon mwen ka neve mwen an pa twò grav epi li se yon kè kontan anpil pou l te alantou. Mwen renmen l anpil e mwen espere avansman li nan lavi a. Li se yon pati bèl bagay nan fanmi nou an e mwen pral yon jou patisipe nan kreye yon souch pou ede timoun yo tou! … Oz
Read all about it here: https://www.leafly.com/news/health/cannabinoid-research-autism-2021
Weed near me.
Don’t forget to check out our NYC dispensary online at cigalar.com We have strains like Bubba kush, White runtz, Apple fritter, White truffle and so much more. Including accessories and edibles.
Doktè Sanjay Gupta ajoute nan koral rechèch Cannabis sou otis nan 2021
Emily Earlenbaugh 20, 2021
Yon dyagnostik otis ka santi lavi-kraze pou paran yo - yon maladi neurodevlopman ki se tou de iremedyabl e souvan difisil pou trete.
Anpil paran timoun ki gen maladi spectre otis rapòte ke konpoze nan Cannabis ka pafwa ede. Men, egzakteman ki jan kanabinoid yo ka ede, ak ki jan yo sèvi ak yo rete klè, akòz blokaj rechèch US la ki dire lontan sou 'marigwana'.
2021 saw some big advances in both research and visibility for this alternative treatment—from a CNN special on Sunday, to a clinicians’ conference in November that relayed reems of new research.
Autism-enkurabl, k ap monte, yon sib terapi Cannabis
Five key things toor ‘Autism Spectrum Disorder’ presents as a wide array of behaviors from mild to severe with cognitive deficits in things like talking, eye-contact, and/or repetitive behaviors.
Its prevalence is now at 1 in 44 eight-year-olds in the US. It’s as high as 1 in 26 in California—where screening and robust services may have driven up diagnoses, the Washington Post reports.
“Advanced parental age (particularly paternal age) has been identified as one of the most important risk factors of autism,” researchers have concluded. Mutations in over 100 genes controlling neurodevelopment seem to lead to malfunctional nervous systems in sufferers.
Nan kèk ka, sistèm siyal nève kò a-sistèm endocannabinoid-sanble yo pa bon. Depi Cannabis chanje fason sistèm endocannabinoid fonksyone, moun ki soufri ASD ka benefisye, rapò ka yo endike.
That’s important—since there are no FDA-approved drugs for core ASD symptoms, and only two for irritability.
Doktè Sanjay Gupta pran yon gade
One big step for cannabis’ visibility as a treatment for autism and its symptoms was the recent CNN special with Dr. Sanjay Gupta MD, WEED 6: Cannabis and Autism, which aired Sunday, 19.
Nan espesyal la, Doktè Gupta te entèvyouve plizyè fanmi ki te jwenn siksè "mirakile" ak Cannabis pou sentòm otis pitit yo. Chèchè, doktè, pasyan otis, ak fanmi yo detaye kijan Cannabis ka chanje lavi pou moun ki gen ASD.
"Nou wè kèk chanjman trè enpresyonan."
Dr Doris Trauner, Pwofesè nan nerosyans ak pedyatri nan UC San Diego
"Nou wè kèk chanjman trè enpresyonan," te di Dr Doris Trauner, Pwofesè nan nerosyans ak pedyatri nan UC San Diego.
Doktè Trauner te di ke agresyon kèk timoun otis yo "ale."
Wed 6 premye dimanch. (CNN)
"Mwen vle di ale," Dr Trauner te di. "Anpil nan timoun yo pi sosyal."
Fourteen states allow medical cannabis for severe autism, Dr. Gupta noted. Sometimes cannabis works for chronic, intractable, autism symptoms like self-injury.
“Paran sa yo te eseye tout bagay—ki gen ladan dwòg sikotwòp pwisan. … Li fè kè. [Avèk Cannabis], fanmi sa yo jwenn yon bagay yo panse ki mache."
Dr. Gupta has shifted the cultural dialog —beginning with WEED, their original cannabis special that highlighted the journey of children with epilepsy finding great benefit from CBD. Massive mainstream viewership promises to bring similar attention to cannabis’ potential benefits for autism.
Doktè Sanjay Gupta rakonte rechèch Cannabis pou sentòm otis yo antre nan faz etid doub avèg, ki kontwole plasebo. (CNN)
Espesyal la disponib kounye a sou demann atravè sistèm kab/satelit, platfòm CNNgo ak aplikasyon mobil CNN.
Sosyete Klinisyen Cannabis konfere dijitalman
Cannabis clinicians that actually treat autistic kids also collaborated like never before in the digital conference Navigating The Complexities of Autism & Cannabis: Facts vs. Myths Nov. 28. The Society of Cannabis Clinicians nonprofit brought together eight doctors and parents of autistic children to review research and outline treatments that were working.
Pandan sesyon an, anpil doktè (tankou de paran pasyan otis yo) te pale sou siksè yo te wè lè l sèvi avèk Cannabis pou otis—detaye tretman patikilye cannabinoid ki te travay byen.
THC vs CBD pou otis
Doktè yo rapòte yon gwo siksè nan mond reyèl la ak THC, prensipal engredyan aktif nan Cannabis. Kontrèman, pifò rechèch cannabinoid sou otis gen tandans konsantre sou CBD. Se paske medikaman Ameriken an rete mefye de THC, klinisyen Cannabis di.
"Literati a byen lwen dèyè sa nou ap fè ak pasyan yo" eksplike Dr Bonni Goldstein MD, pandan konferans lan. "Mwen panse ke yon pati nan sa a se toujou difikilte pou aksepte ke Cannabis pral ede timoun sa yo" li te ajoute, eksplike ke anpil moun toujou pè efè segondè THC.
Men, Goldstein ak lòt moun te pataje ke pasyan otis yo ki itilize THC yo ap fè byen. "Pifò nan nou pa wè okenn efè segondè enpòtan."
Doktè Justin Sulak te fè lwanj tou benefis THC pou pasyan otis yo, li eksplike ke THC ka pi bon fason pou rann kont defisyans nerochimik yo wè nan pasyan otis yo. Espesyalman, anandamid molekil 'bonheur' kò a. THC travay menm jan ak anandamid.
Pasyan medikal yo itilize pwodwi tankou "Care By Design" mak ki gen lisans Kalifòni, ki ofri rapò espesifik CBD ak THC. (Swen koutwazi pa konsepsyon)
"Petèt CBD ka itilize pou simulation anandamid, men mwen panse ke THC pral zouti ki pi itil. Se konsa, si yon moun gen defisyans sa a, pou di konsa, li fè sans pou trete ak THC.
Still, while THC was highlighted, doctors shared that a variety of different cannabinoids—including CBD, CBDA, THCA, and CBG —all seemed to offer beneficial effects for autistic patients.
Cannabis pou rechèch otis awondi
Doktè yo tou mete aksan sou anpil etid sou cannabinoids pou ASD nan 2021—yon lòt gwo viktwa.
Dr. Patricia Frye, MD, the headliner for the conference, explained research dates to 2016, when a study concluded enhancing anandamide could help with autism. But research interest grew in the last few years.
"Nan 2021...nou gen pi plis ak plis done preklinik ak obsèvasyon, gade espesyalman nan risk ak benefis Cannabis ak cannabinoids nan trete tou de kondisyon debaz ak ko-egzistan."
Yon douzèn nouvo etid te gade benefis Cannabis pou otis, sa ki fè 2021 yon gwo ane pwogrè.
Cannabis diminye biomarqueurs de mal
This November, Dr. Bonni Goldstein published new research showing cannabis cut levels of biomarkers for nerve-swelling, aggressiveness, and pain. Autistic patients’ abnormally high biomarkers came back into normal ranges after a year of treatment, Dr. Goldstein concludes.
Chanjman sa yo nan byomarkè korelasyon ak konpòtman amelyore, dapre rapò paran pasyan otis yo.
Doktè Goldstein di tès biomakè sa yo ta ka ede mezire efikasite tretman cannabinoid pou otis.
2022 pwomèt pou wè plis pwogrè nan konpreyansyon nou sou fason pou trete otis. Pou kèk nan yo estime 75 milyon moun ki gen ASD nan mond lan, repons yo ta ka chanje lavi yo.
Cannabinoids pou otis—Rechèch kle
Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder; Cannabis and cannabinoid research; 2021; “biomarkers shifted toward the mean after [cannabis] treatment and can potentially quantify benefit at the metabolic level. These changes appear to be similar to the trend described in behavior surveys.”
Cannabinoid treatment for autism: a proof-of-concept randomized trial; Molecular Autism; 2021; Disruptive behavior … was either “much or very much improved” in 49% [of patients] on whole-plant extract (20:1 CBD:THC tincture); “Further testing of cannabinoids in ASD is recommended.”
Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications; Cannabis and Cannabinoids Research; 2021; “CBD-rich medical cannabis seems to be an effective, tolerable, and relatively safe option for many symptoms associated with ASD, however, the long-term safety is unknown at this time.”
Cannabinoids for people with ASD: a systematic review of published and ongoing studies; Brain Science; 2020; “The findings were promising, as cannabinoids appeared to improve some ASD-associated symptoms, such as problem behaviors, sleep problems, and hyperactivity, with limited cardiac and metabolic side effects.”
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy; Nature; 2019; 30% of patients reported “significant improvement” on CBD+THC; “Cannabis in ASD patients appears to be well tolerated, safe and effective option to relieve symptoms associated with ASD.”
Lower circulating endocannabinoid levels in children with autism spectrum disorder. Molecular Autism; 2019
Brief Report: Cannabidiol-rich cannabis in children with autism spectrum disorder and severe behavioral problems-a retrospective feasibility study; Journal of Autism Developmental Disorder; 2019; “Following the cannabis treatment, behavioral outbreaks were much improved or very much improved in 61% of patients.”
Effects of CBD-enriched cannabis sativa extract on autism spectrum disorder symptoms: an observational study of 18 participants undergoing compassionate use; Frontiers of Neurology; 2019; “The results reported here are very promising and indabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbiditieer. Molecular Autism; 2018; “these data suggest that impaired anandamide signaling may be
.png)
Comments